IPHA - Innate falls on updated phase 1/2 data on blood cancer asset teamed with Sanofi
2024-06-17 12:55:20 ET
More on Sanofi, Innate Pharma
- Sanofi's Immunology Business Is Doing A Lot Of Heavy Lifting
- Sanofi: A Leader In Life-Saving Vaccines And Treatments
-
Regeneron, Sanofi win FDA label expansion for arthritis therapy Kevzara
- Innate Pharma S.A. (IPHA) Q1 2024 Earnings Call Transcript